Clindamycin is a semi-synthetic lincosamide antibiotic derived from lincomycin. It is used as a pharmaceutical raw material in the manufacturing of products indicated for serious infections caused by susceptible anaerobic bacteria and certain gram-positive and gram-negative organisms, as well as for topical acne vulgaris treatment.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 18323-44-9
Clindamycin hydrochloride
pharmaceutical raw material
Clindamycin hydrochloride monohydrate
pharmaceutical raw material
Lincomycin hydrochloride
pharmaceutical raw material
Lincomycin
pharmaceutical raw material
Erlotinib hydrochloride
pharmaceutical raw material
Erlotinib
pharmaceutical raw material
Ethyl 4-(8-chloro-3-hydroxy-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
pharmaceutical raw material
Abarelix
pharmaceutical raw material
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
KDLRVYVGXIQJDK-AWPVFWJPSA-N
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl